Xu Han
- Molecular Biology top 5%
- Cancer Research top 1%
- Immunology top 10%
- Oncology top 10%
- Biomedical Engineering top 10%
- Co-authors
- Wing‐Kin SungYijun RuanChia‐Lin WeiMengquan LiHuck‐Hui NgKuo Ping ChiuXiao Dong ZhaoAtif Shahab
- Topics
- RNA modifications and cancer (19 papers)Cancer-related molecular mechanisms research (17 papers)MicroRNA in disease regulation (13 papers)
- Partner nations
- ChinaSingaporeUnited States
In The Last Decade
Xu Han
74 papers receiving 3.2k citations
Hit Papers
Peers
Comparison fields: 5 of 123
- Molecular Biology 2.5k
- Cancer Research 1.1k
- Immunology 420
- Oncology 372
- Biomedical Engineering 329
Countries citing papers authored by Xu Han
This map shows the geographic impact of Xu Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xu Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xu Han more than expected).
Fields of papers citing papers by Xu Han
This network shows the impact of papers produced by Xu Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xu Han. The network helps show where Xu Han may publish in the future.
Co-authorship network of co-authors of Xu Han
This figure shows the co-authorship network connecting the top 25 collaborators of Xu Han. A scholar is included among the top collaborators of Xu Han based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xu Han. Xu Han is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 7 | |
| 3 | 4 | |
| 4 | 3 | |
| 5 | 0 | |
| 6 | 4 | |
| 7 | 6 | |
| 8 | 13 | |
| 9 | Hybrid cellular membrane nanovesicles amplify macrophage immune responses against cancer recurrence and metastasisbreakdown → | 307 |
| 10 | 18 | |
| 11 | 15 | |
| 12 | 20 | |
| 13 | 31 | |
| 14 | 8 | |
| 15 | 8 | |
| 16 | 128 | |
| 17 | 10 | |
| 18 | 204 | |
| 19 | 6 | |
| 20 | 153 |
About Xu Han
Xu Han is a scholar working on Cancer Research, Molecular Biology and Biochemistry, having authored 77 papers that have together received 3.2k indexed citations. Recurring topics across this work include RNA modifications and cancer (19 papers), Cancer-related molecular mechanisms research (17 papers) and MicroRNA in disease regulation (13 papers). The work is most often cited by research in Cancer Research (1.1k citations), Molecular Biology (2.5k citations) and Immunology (420 citations). Xu Han has collaborated with scholars based in China, Singapore and United States. Frequent co-authors include Wing‐Kin Sung, Yijun Ruan, Chia‐Lin Wei, Mengquan Li, Huck‐Hui Ng, Kuo Ping Chiu, Xiao Dong Zhao, Atif Shahab, Keke Miao and Yuriy L. Orlov. Their work appears in journals such as Nature Communications, Molecular Cell and Bioinformatics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.